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Summary Minisatellite DNA probes which can detect a large number of autosomal loci dispersed
throughout the human genome were used to examine the constitutional and tumour DNA of 35 patients with
a variety of cancers of which eight were of gastrointestinal origin. Somatic changes were seen in the tumour
DNA in ten of the 35 cases. The changes included alterations in the relative intensities of hybridising DNA
fragments, and, in three cases of cancers of gastrointestinal origin, the appearance of novel minisatellite
fragments not seen in the corresponding constitutional DNA. The results of this preliminary study suggests
that DNA fingerprint analysis provides a useful technique for identifying somatic changes in cancers.
It is now widely accepted that tumours arise through the
accumulation of several genetic changes affecting the control
of cell proliferation (Klein & Klein, 1985). Over 30 different
cellular loci presumably involved in these pathways have
now been identified (Barbacid, 1986). These genes have been
designated oncogenes whereas their counterparts in normal
cells are referred to as proto-oncogenes. Activation of the
cellular oncogenes is thought to be an important step in the
development of neoplasia, and the somatic change which
causes this activation can be a gross chromosomal trans-
location or just a single point mutation (Barbacid, 1986).
Somatic changes which result from major chromosomal
rearrangements are detectable by karyotype analysis
(Sandberg, 1980; Yunis, 1983) although chromosomal
preparations from solid tumours can be technically difficult.
DNA analysis can also detect somatic variations; in parti-
cular, chromosomal loss or the development of somatic
homozygosity can now be demonstrated by restriction
fragment length polymorphism (RFLP) analysis using single
copy gene probes (Wainscoat & Thein, 1985). This approach
is ideal for the study of tumours such as retinoblastoma
(Cavenee et al., 1983) or Wilms' tumour (Koufos et al.,
1984; Orkin et al., 1984; Reeve et al., 1984) in which there is
a consistent loss of a particular chromosomal region. For
other tumours a battery of DNA probes representing
different loci may be used to detect chromosomal loss
(Dracopoli et al., 1985).
We describe here an alternative approach for screening the
human genome for somatic changes in cancers using DNA
fingerprint analysis. DNA fingerprints represent multiple
hypervariable fragments derived from a large number of
autosomal loci dispersed throughout the human genome and
show both somatic and germline stability (Jeffreys et al.,
1985a, b, 1986). We have analysed the constitutional and
tumour DNA of 35 cancer patients and observed somatic
changes in the tumour DNA in ten cases. The changes
include alterations in the relative intensities of hybridising
DNA fragments, and, in three cases of cancers of gastro-
intestinal origin, the generation of novel minisatellite
fragments not seen in the corresponding constitutional
DNA.
Materials and methods
Patients
Thirty-five patients with a variety of cancers were studied
(Table I). The diagnoses of the solid tumours were made by
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histological examination and the cases of myelodysplasia
(MDS), all of which had karyotypic abnormalities, fulfilled
the FAB classification (Bennett et al., 1982). All tissues and
peripheral blood leucocytes were obtained before chemo-
therapy or radiotherapy. DNA was isolated from tumour
tissues (representing tumour DNA), from peripheral blood
leucocytes (representing constitutional DNA) and, in some
cases, from adjacent normal tissue. In the MDS patients,
tumour DNA was obtained from bone marrow or peripheral
blood leucocytes and constitutional DNA from Epstein-Barr
virus (EBV)-transformed B-cells.
DNA Analysis
DNA was isolated from peripheral blood leucocytes by
proteinase-K and phenol-chloroform extraction as described
(Old & Higgs, 1983). The fresh solid tissues were dissected
free of fat, minced and digested overnight at 37°C in 0.5%
SDS and proteinase-K; DNA was subsequently isolated by
phenol-chloroform extraction as for the leucocytes.
Equivalent amounts of constitutional or tumour DNA (8-
10 g) from each individual were digested with HinfI, AluI
and HaeIII under conditions recommended by the manu-
facturers (Boehringer Mannheim), in the presence of
spermidine trichloride and recovered by ethanol precipi-
tation. The resultant DNA fragments of the constitutional
and tumour DNA of each patient were electrophoresed in
adjacent tracks through a 22cm long 1.0% agarose gel at
35 V for 36h at room temperature until all DNA
fragments <2kb long had electrophoresed off the gel. The
separated DNA fragments were transferred to a Schleicher
and Schull nitrocellulose membrane (BA 85) and hybridised
to 32P-labelled minisatellite probe 33.15 or 33.6 as described
elsewhere (Jeffreys et al., 1985a, b). After hybridisation,
filters were washed for 1 h in 1 x SSC at 65'C and autoradio-
graphed without intensifying screens for 3-4 days at -70°C.
Results
The tumour and constitutional DNA fingerprints were
indistinguishable in the majority (25/35) of cancer patients
studied (Figure 1, Table I). In nine cases, including some
myelomas, breast carcinomas and gastro-intestinal tract
carcinomas, there were shifts in the relative intensities of
hypervariable DNA fragments in the tumour DNA when
compared to the constitutional DNA. In two cases (patients
AC and FB), the shifts in band intensities were also seen in
DNA fingerprints produced after digestion with AluI or
HaeIII confirming that these changes were not due to
tumour-specific DNA methylation changes which could
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Table I Comparison of tumour and constitutional DNA fingerprints in 35 human
cancers
Changes in tumour
DNAfingerprint
DNA Intensity New
Tumour Patient source shift bands
Lymphoma
T-cell 1 PH LN, PB - -
2 LS LN, PB - -
3 WI LN, PB - -
B-cell 4 C1 LN, PB
5 C2 LN, PB - -
6 T1 pleural fluid, PB
Multiple myeloma 7 EL BM, PB +
8 T2 BM, PB - -
9 C3 BM, PB + -
10 H1 BM, PB
11 W2 BM, PB -
12 G BM, PB
13 0 BM, PB + -
Waldenstrom's disease 14 D1 BM, PB
Hodgkin's disease 15 H2 LN., PB
Myelodysplasia 16 K BM, PB, CL
17 C4 PB, CL - -
18 H3 PB, CL - -
19 D2 PB, CL - -
20 B PB, CL - -
21 R2 PB, CL - -
22 U PB, CL - -
23 L PB, CL - -
Breast carcinoma 24 J T, PB -
25 R1 T, PB + -
26 EA T, N, PB + -
27 AG T, N, PB -
Gastric carcinoma 28 HT T, N, PB
29 B T, N, PB + -
Gastro-oesphageal
carcinoma 30 AC T, N, PB + +
Colonic carcinoma 31 BA T, N, PB
32 WM T, N, PB + -
33 GS T, PB - -
Rectal carcinoma 34 PW T, N, PB +
35 FB T, PB + +
Constitutional DNA was represented by DNA from peripheral blood leucocytes
(PB) and in some breast and gastro-intestinal carcinomas from adjacent normal (N)
tissue. Tumour DNA was represented by DNA from lymph-node (LN), cancerous
cells in pleural fluid in case No. 6 (patient T,), bone marrow (BM) and tumour (T)
tissue. In myelodysplasia, tumour DNA was represented by BM or PB and
constitutional DNA by EBV-transformed B lymphocytes (CL). The symbol (+)
indicates presence and (-) absence of changes in tumour DNA fingerprint. The
changes in the tumour DNA fingerprints in patients AC, PW and FB seen after
HinfI digestion, were also produced after digestion with AluI or HaeIII. Shifts in
band intensities alone in seven cases (patients EL, C3, 0, R1, EA, B and WM) might,
in part at least, be related to tumour-specific DNA methylation changes (Goelz et al.,
1985) which could affect HinfI cleavage sites.
affect HinfI cleavage sites and therefore hypervariable DNA
fragment length (HinfI sites terminating in mCG,
GANTmCG, are resistant to HinfI cleavage; McClelland &
Nelson, 1985). In addition, in patient AC where adjacent
normal tissue was available for study, the changes were
present only in tumour tissue but not in the adjacent normal
tissue showing that these changes were specific to tumour
rather than tissue.
Three patients (AC, PW and FB, Table I, Figure 2a)
showed new bands in the tumour DNA fingerprint. Patients
PW and FB had moderately differentiated adenocarcinoma
of the rectum and AC had an undifferentiated adeno-
carcinoma of the gastro-oesophageal junction. Patient PW
showed a novel 14.4kb band in the tumour DNA fingerprint
which was not present in the constitutional DNA finger-
prints of both peripheral blood and adjacent normal tissue.
In addition, the hybridisation signal of a larger 16.2kb
fragment was approximately halved in tumour DNA as
compared to constitutional DNA. No other differences were
noted in the tumour DNA fingerprint. Patient FB showed
two types of changes in the tumour DNA, the presence of a
new band of approximately 10.5kb and a reduction in the
hybridisation intensity in four bands of approximate sizes
5.7, 5.0, 4.0 and 3.1 kb. Patient AC had a novel 4.6kb
fragment, reduced hybridisation signal of a 4.4kb band and
an increased signal of a 2.8kb band in the tumour DNA
fingerprint. These changes in the tumour DNA were con-
firmed by hybridisation of probe 33.15 to DNA digested
with AluI and HaeIII (Figure 2b). Furthermore, the changes
occurred in bands of similar sizes, as expected since HinfI,
AluI and HaeIII, which cleave at 4bp sequences that are
unlikely to be present in the tandem repeat sequence, should
each release a minisatellite in a similar sized fragment.
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Figure 1 Representative constitutional and tumour DNA finger-
prints of human cancers. The tumour types are shown above the
autoradiographs. Lanes C and C1 represent constitutional DNA
from peripheral blood leucocytes or EBV-transformed lympho-
cytes; C2, constitutional DNA from adjacent normal tissue, and
lanes T, tumour DNA. MM - multiple myeloma, MDS -
myelodysplasia, Ca colon - carcinoma of the colon and breast -
breast carcinoma. Note that the tumour and constitutional DNA
fingerprints in these cases are indistinguishable.
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DNAs of patients PW, FB and AC with minisatellite probe
33.6, which detects hypervariable DNA fragments derived
from a different set of loci (Jeffreys et al., 1986), did not
show any differences between tumour and constitutional
DNA fingerprints (data not shown).
Discussion
Cancer is a multistep process that probably results from an
accumulation of a series of somatic changes. DNA finger-
print analysis provides a useful new approach for studying
some of these somatic changes in tumour DNA. A number
of processes could result in the alteration of DNA finger-
prints. For example, loss of chromosomes or chromosomal
regions through deletion, mitotic nondisjunction or mitotic
recombination would lead to loss of associated minisatellite
fragments. Conversely, localised amplification of DNA
(Stark & Wahl, 1984; Schimke, 1984) including a mini-
satellite would cause specific band intensification. Tissue- or
tumour-specific changes in DNA methylation (Goelz et al.,
1985) could also affect DNA fingerprints; the latter can be
excluded by using restriction enzymes such as AluI and
HaeIII the cleavage sites of which are not blocked by CpG
methylation. Of considerable interest is the appearance of
novel fragments in tumour DNA fingerprints. These bands
presumably arise by length changes of pre-existing mini-
satellites, perhaps by unequal sister-chromatid exchange.
Thus the novel 14.4kb band in patient PW appears to have
arisen by contraction of the larger 16.2kb fragment which is
still present although at reduced intensity in the tumour
DNA fingerprint. The 1.8kb deletion relationship between
the larger and mutant bands is also seen in AluI and HaeIII
digests, as expected if the 16.2kb band is the precursor of
the 14.4kb mutant fragment. The retention of the parental
fragment in tumour DNA suggests that the tumour is
comprised of a mixed population of parental and mutant
cells; the alternative explanation that PW is homozygous for
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Figure 2 (a) Comparison of the constitutional and tumour DNA fingerprints produced after HinfI digestion in 3 cancer patients.
The patients' initials are shown above the blots and correspond to details given in Table I. Lanes 1 represent constitutional DNA
from peripheral blood leucocytes, lanes 2, tumour DNA and lanes 3, constitutional DNA from adjacent normal tissue. The
symbol 4 indicates the position of novel bands and shifts in band intensities seen in the tumour DNA fingerprints, AC - 4.6, 4.4,
2.8 kb, PW - 16.2, 14.4kb and FB - 10.5, 5.7, 5.0, 4.0, 3.1 kb. These changes were also seen after digestion with AluI or HaeIII.
(b) Comparison of the tumour and constitutional DNA fingerprints in patient PW. Lanes 1 - constitutional DNA from peripheral
blood leucocytes, lanes 2 - tumour DNA, lanes 3 - constitutional DNA from adjacent normal tissue. The symbol 4 indicates the
position of the novel band present in tumour DNA after digestion with HinfI, AluI, and HaeIII. Its probable progenitor band is
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the 16.2kb fragment and that the tumour is heterozygous for
the new mutant band is less likely in view of the high level of
heterozygosity of large minisatellite fragments (Jeffreys et al.,
1985b).
Thirty-five different tumours of which eight were of
gastro-intestinal origin have been studied. Mutant bands in
tumour DNA fingerprints were observed in three cases, all of
gastro-intestinal origin (two rectal and one gastro-
oesophageal carcinoma). In two cases where adjacent normal
tissue was available for study, no changes were seen on
comparing normal tissue and blood DNA fingerprints. This
suggests that the somatic mutations seen are tumour specific
rather than tissue specific. However, it is not clear whether
these novel bands are related to the pathogenesis of the
tumour, or whether they are the products of unequal mitotic
recombination events which arise in all tissues but only
become apparent on clonal expansion of a malignant cell. In
any event, such changes even though not directly related to
the tumour phenotype could provide novel markers for
studying tumour clonality and tumour progression. Also, it
is presently not possible to determine whether the somatic
mutations observed in the three gastro-intestinal tumours
involve the same locus. It should be possible to clone the
clearly-resolved mutant minisatellite from patient PW to
provide a locus-specific probe (Wong et al., 1986) suitable
for studying the tumours from patients FB and AC which
should help to resolve the issue of whether the genomic
rearrangements in the tumours of patients PW, FB and AC
involve a common chromosomal region.
Recently, an oncogene (onc-D or trk) has been isolated
from the DNA of a human carcinoma of the colon and was
shown to have arisen by recombination between two
separate loci (Martin-Zanca et al., 1986). It is possible that
an enhanced level of recombination occurs in many tumours,
rearranging both oncogenes and minisatellites. Some of these
rearrangements are detectable by karyotype analysis e.g.
generation of the Philadelphia chromosome in chronic
myeloid leukaemia (Heisterkamp et al., 1983) and trans-
location of the c-myc oncogene in Burkitt's lymphoma
(Yunis, 1983). In view of the evidence that the majority of
the cancers show substantial genetic rearrangement it might
have been expected that a higher proportion of the tumours
analysed would have shown differences in the DNA finger-
prints as compared to the constitutional DNA. One
explanation for this unexpected finding is that the DNA
fingerprints obtained from the minisatellite probe 33.15 are
derived from an estimated number of 30 loci (Jeffreys et al.,
1986) and therefore will not detect aneuploidy or
hemizygosity over a large proportion of the human genome.
Nevertheless, DNA fingerprinting analysis offers another
approach to the detection of previously uncharacterised
genomic rearrangements. Locus-specific hybridisation probes
could be prepared from a mutant minisatellite and then used
both to determine the frequency of genomic rearrangements
at this locus in other cancers and to localise the minisatellite
within the human genome. This approach is currently being
tested by cloning the mutant minisatellite from patient PW.
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